Terkko Navigator / European Respiratory Journal

Methacholine reactivity in LAM is inversely related to FEV₁ and VEGF-D

Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore

Perspectives on palliative oxygen for breathlessness: Systematic review and meta-synthesis

Association of dyspnea, mortality, and resource use in hospitalised patients

Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze

The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease

The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment

The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference (MCID)

The pathophysiological role of novel pulmonary arterial hypertension gene <em>SOX17</em>

Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort

Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy

Fine particulate matter and out-of-hospital cardiac arrest of respiratory origin

Classification and effectiveness of different oxygenation goals in mechanically ventilated critically ill patients: network meta-analysis of randomised controlled trials

Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease

Honing in on the effectors of oxidative stress in the asthmatic lung: oxidised phosphatidylcholines

Reply: BAL lymphocyte percentage is as good as the company it keeps

Comment on: Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis

Is high-dose glucocorticoid beneficial in COVID-19? Response to Correspondence

Single-cell RNA sequencing identifies macrophage transcriptional heterogeneities in granulomatous diseases

Effect of corrected GLI reference equations on carbon monoxide transfer factor interpretation

Dynamics of SARS-CoV-2 shedding in the respiratory depends on the severity of disease in COVID-19 patients

Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life

Lung function &amp; cardiovascular disease. A Two Sample Mendelian Randomisation Study

Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model

Diffusion Capacity Abnormalities for Carbon Monoxide in Patients with COVID-19 At Three-Month Follow-up

Can Simvastatin reduce COPD Exacerbations? A Randomised Double Blind Controlled Study

Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening

Point-of-care lung ultrasound assessment for risk stratification and therapy guiding in COVID-19 patients. A prospective non-interventional study

Expectation and dyspnea: The neurobiological basis of respiratory nocebo effects

Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal <em>versus</em> nasopharyngeal swab

Corticosteroids in Covid-19: One size does not fit all

Chest x-ray or CT for COVID-19 pneumonia? Comparative study in a simulated triage setting

The case of methotrexate and the lung: Dr Jekyll and Mr Hyde

Preventing cardiovascular events after pneumonia with aspirin: one step forward, but still many to go

COPD frequent exacerbators: time for the recycle bin?

When things go wrong: Exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases

Eradication success for non-tuberculous mycobacteria in children with cystic fibrosis

Ethical obligations for supporting healthcare workers during the COVID-19 pandemic

Task Force report: European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis

Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg^-1 rifampicin

Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation

Same-day repeatability of fractional exhaled nitric oxide in severe asthma

Personal exposure to air pollution and respiratory health of COPD patients in London

Optimising pyrazinamide for the treatment of tuberculosis

Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19

Genome-wide association study in patients with pulmonary <em>Mycobacterium avium</em> complex disease

Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis

Reply: About the recommendation of the GINA strategy report on asthma step 1

Early discharge after acute pulmonary embolism: keep quality of life on the radar

About the recommendation of the GINA strategy report on asthma step 1